Ph.D., VP, Computational Biology, PatientsLikeMe
A molecular biologist by training, Renee has spent the last decade guiding drug discovery and biomarker development by designing and building high resolution molecular models of disease, and creating systems that find meaning in big biological data. Her team of biologists and computational biologists are spearheading our most innovative projects, which are focused on using modeling strategies such as deep learning and neural network applications to understand the molecular underpinnings of health and disease. Renee was previously Senior Vice President of Research and Chief Scientific Officer at Selventa. In that role, she set the scientific direction for the company’s personalized medicine strategy and built a multidisciplinary team of biologists and computational biologists to characterize disease biology and identify target pathways. Before that Renee was Selventa’s Senior Director of Scientific Research Operations, responsible for designing and building the company’s biomarker discovery platform.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: Annotated human biospecimens are critical building blocks for precision medicine discovery and essential to the preclinical validation of resulting hypotheses. In this session, learn how advances in technology are improving access to a diverse range of biospecimens from patient populations and yielding increasingly useful amounts of information upon analysis.